Fungal Vaccines and Vaccination: Problems and Perspectives
Author:
Cassone Antonio MD
Publisher
Springer Netherlands
Reference60 articles.
1. Beninati, C., Oggioni M.R., Boccanera, M., Spinosa, M.R., Maggi, T., Conti, S., Magliani, W., De Bernardis, F., Teti, G., Cassone, A., Pozzi, G. and Polonelli, L. (2000) Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 18, 1060–1064. 2. Bohn, J.A., BeMiller, J.N. (1995) Carbohydr. Polym. 28, 3–14. 3. Bozza, S., Montagnoli, C., Gaziano, R., Rossi, G., Nkwanyuo, G., Belloccio, S. and Romani, L. (2004) Dendritic cel-based vaccination against opportunistic fungi. Vaccine 22, 857–864. 4. Brian Mochon, A., Cutler, E. (2005) Is a vaccine needed against Candida albicans? Med. Mycol. 43, 97–115. 5. Bromuro, C., Torosantucci, A., Chiani, P., Conti, S., Polonelli, L. and Cassone, A. (2002) Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun. 70, 5462–5470.
|
|